We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-5.51%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$285M
AUM Growth
-$94.6M
Cap. Flow
-$78.6M
Cap. Flow %
-27.58%
Top 10 Hldgs %
56.44%
Holding
82
New
19
Increased
11
Reduced
16
Closed
32

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$17M
2
QGEN icon
Qiagen
QGEN
+$15.8M
3
ICLR icon
Icon
ICLR
+$11.1M
4
ZTS icon
Zoetis
ZTS
+$7.11M
5
BAX icon
Baxter International
BAX
+$6.52M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$15.9M
2
BMY icon
Bristol-Myers Squibb
BMY
+$14.2M
3
OFIX icon
Orthofix Medical
OFIX
+$14.2M
4
CNC icon
Centene
CNC
+$12.5M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$9.98M

Sector Composition

Rank Sector Weight
1 Healthcare 70.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
76
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-15,342
Closed -$1.95M
SYNH
77
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-123,232
Closed -$9.98M
MTEM
78
DELISTED
Molecular Templates, Inc.
MTEM
– –
-20,949
Closed -$1.08M
PHAS
79
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-243,795
Closed -$322K
BHVN
80
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-15,400
Closed -$1.83M
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Endurant Capital Management held 82 positions worth $285M, down 25% from $380M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Endurant Capital Management withdrew a net $78.6M in Q2 2022, closing 32 positions and reducing 16 holdings. Its most notable exit was AstraZeneca, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 70% a quarter earlier.

Against the trend, Endurant Capital Management opened a new position in Boston Scientific worth $15.6M.

  • Endurant Capital Management's largest Q2 2022 buy was Boston Scientific: 418,165 shares worth $15.6M.
  • Endurant Capital Management added most to Qiagen in Q2 2022, an estimated $15.8M increase.
  • Endurant Capital Management's biggest Q2 2022 reduction was Centene, cutting an estimated $12.5M.
  • Endurant Capital Management fully exited AstraZeneca in Q2 2022, selling an estimated $15.9M.
  • Endurant Capital Management's ten largest holdings make up 56% of its $285M portfolio in Q2 2022.
  • Endurant Capital Management opened 19 new positions and closed 32 in Q2 2022.
  • Endurant Capital Management's portfolio value fell 25% quarter-over-quarter to $285M.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.